Inspire Medical Systems, Inc.

INSP Healthcare Medical Devices

Inspire Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $912.0 million, up 13.6% from fiscal 2024.

Revenue
−7.93%
EPS
−348.0%
Free cash flow
−33.1%

Quarter to September 2026, against a year earlier

64.22 2.31 −3.47%
Market cap
$1.9B
P/E
19.1×
Fwd P/E
−1,627×
Dividend yield
—
F-score
6/9
Altman Z
14.49
Beneish M
−1.88
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
19.95 9.57 11.39 18.37

+8 more quarters

P/S ratio
2.28 1.43 1.62 2.97
P/FCF ratio
20.50 10.99 15.31 34.52
P/Operating CF
43.22 55.38 115.21 51.62
P/B ratio
2.43 1.56 1.87 3.47
EV/Sales
1.92 1.09 1.32 2.64
EV/EBITDA
50.93 13.93 18.45 38.86
EV/FCF
17.25 8.33 12.47 30.71
Current Ratio
6.45 8.55 6.34 6.08
Net Debt/EBITDA
13.69 (83.38) (76.67) (6.22)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
5.01% 10.45% 8.78% 5.44%
Free Cash Flow Yield
4.88% 9.10% 6.53% 2.90%
Free Cash Flow per Share
1.34 0.49 0.11 1.42
Book value per Share
28.59 28.63 27.61 26.60
Free Cash Flow
38.88 14.07 3.12 41.81
EV/EBIT
107.11 18.02 23.51 47.30
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026